Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Status:
Recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The trial will test the effectiveness and toxicity of subcutaneous treatment with one cycle
of cladribine in patients with hairy cell leukemia requiring treatment.
They have to be untreated so far or may be pretreated with alpha-interferon.